UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2016 UpToDate®

Virology, epidemiology, and pathogenesis of JC polyomavirus, BK polyomavirus, and other human polyomaviruses

Author
Hans H Hirsch, MD, MSc
Section Editor
Martin S Hirsch, MD
Deputy Editor
Anna R Thorner, MD

INTRODUCTION

Polyomavirus infections have been detected in vertebrate hosts including rodents, cattle, birds, monkeys, and primates. Despite some common features shared with papillomaviruses, including an oncogenic potential, polyomaviruses are now recognized as members of the separate genus Polyomavirus in the Polyomaviridae family of the ungrouped DNA viruses [1].

The virology, epidemiology, and pathogenesis of human polyomavirus (HPyV) infections will be provided here. An overview of the clinical manifestations and diagnosis of polyomavirus (PyV) infections is presented separately. Disease manifestations caused by HPyVs, including progressive multifocal leukoencephalopathy, PyV-associated nephropathy, and ureteral stenosis, are discussed in detail elsewhere. (See "Overview of JC polyomavirus, BK polyomavirus, and other polyomavirus infections" and "Progressive multifocal leukoencephalopathy: Epidemiology, clinical manifestations, and diagnosis" and "Natalizumab for relapsing-remitting multiple sclerosis in adults", section on 'Risk of PML' and "Progressive multifocal leukoencephalopathy: Treatment and prognosis" and "Clinical manifestations and diagnosis of BK virus-induced (polyomavirus-induced) nephropathy in kidney transplantation" and "Prevention and management of BK virus-induced (polyomavirus-induced) nephropathy in kidney transplantation".)

CLASSIFICATION

Human polyomaviruses — Multiple species of human polyomavirus (HPyV) have been identified:

Human polyomavirus 1, called BK polyomavirus (BKPyV), and human polyomavirus 2, called JC polyomavirus (JCPyV), were named after the initials of the patients from whom they were first isolated in 1971 [2,3].

Human polyomavirus 3, called KI polyomavirus (KIPyV), and human polyomavirus 4, called WU polyomavirus (WUPyV), were named after the institutions of their first discovery in 2007 (Karolinska Institute, Stockholm, Sweden [4], and Washington University St. Louis, USA) [4,5]. (See "Overview of JC polyomavirus, BK polyomavirus, and other polyomavirus infections", section on 'Disease associations'.)

               

Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Nov 2016. | This topic last updated: Thu Oct 01 00:00:00 GMT+00:00 2015.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2016 UpToDate, Inc.
References
Top
  1. Imperiale MJ, Major EO. Polyomaviruses. In: Fields Virology, 5th ed, Knipe DM, Howley PM (Eds), Lippincott Williams & Wilkins, Philadelpha 2007. Vol 2, p.2263.
  2. Gardner SD, Field AM, Coleman DV, Hulme B. New human papovavirus (B.K.) isolated from urine after renal transplantation. Lancet 1971; 1:1253.
  3. Padgett BL, Walker DL, ZuRhein GM, et al. Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy. Lancet 1971; 1:1257.
  4. Allander T, Andreasson K, Gupta S, et al. Identification of a third human polyomavirus. J Virol 2007; 81:4130.
  5. Gaynor AM, Nissen MD, Whiley DM, et al. Identification of a novel polyomavirus from patients with acute respiratory tract infections. PLoS Pathog 2007; 3:e64.
  6. Feng H, Shuda M, Chang Y, Moore PS. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 2008; 319:1096.
  7. Schowalter RM, Pastrana DV, Pumphrey KA, et al. Merkel cell polyomavirus and two previously unknown polyomaviruses are chronically shed from human skin. Cell Host Microbe 2010; 7:509.
  8. Ho J, Jedrych JJ, Feng H, et al. Human polyomavirus 7-associated pruritic rash and viremia in transplant recipients. J Infect Dis 2015; 211:1560.
  9. van der Meijden E, Janssens RW, Lauber C, et al. Discovery of a new human polyomavirus associated with trichodysplasia spinulosa in an immunocompromized patient. PLoS Pathog 2010; 6:e1001024.
  10. Scuda N, Hofmann J, Calvignac-Spencer S, et al. A novel human polyomavirus closely related to the african green monkey-derived lymphotropic polyomavirus. J Virol 2011; 85:4586.
  11. Ehlers B, Wieland U. The novel human polyomaviruses HPyV6, 7, 9 and beyond. APMIS 2013; 121:783.
  12. Mishra N, Pereira M, Rhodes RH, et al. Identification of a novel polyomavirus in a pancreatic transplant recipient with retinal blindness and vasculitic myopathy. J Infect Dis 2014; 210:1595.
  13. Engels EA, Switzer WM, Heneine W, Viscidi RP. Serologic evidence for exposure to simian virus 40 in North American zoo workers. J Infect Dis 2004; 190:2065.
  14. System, E.E.P.A. 2010. Polyomaviruses. In: Swiss Institute of Bioinformatics.
  15. Funk GA, Gosert R, Comoli P, et al. Polyomavirus BK replication dynamics in vivo and in silico to predict cytopathology and viral clearance in kidney transplants. Am J Transplant 2008; 8:2368.
  16. Unterstab G, Gosert R, Leuenberger D, et al. The polyomavirus BK agnoprotein co-localizes with lipid droplets. Virology 2010; 399:322.
  17. Khalili K, White MK, Sawa H, et al. The agnoprotein of polyomaviruses: a multifunctional auxiliary protein. J Cell Physiol 2005; 204:1.
  18. Seo GJ, Fink LH, O'Hara B, et al. Evolutionarily conserved function of a viral microRNA. J Virol 2008; 82:9823.
  19. Gosert R, Rinaldo CH, Funk GA, et al. Polyomavirus BK with rearranged noncoding control region emerge in vivo in renal transplant patients and increase viral replication and cytopathology. J Exp Med 2008; 205:841.
  20. Gosert R, Kardas P, Major EO, Hirsch HH. Rearranged JC virus noncoding control regions found in progressive multifocal leukoencephalopathy patient samples increase virus early gene expression and replication rate. J Virol 2010; 84:10448.
  21. Hirsch HH, Steiger J. Polyomavirus BK. Lancet Infect Dis 2003; 3:611.
  22. Weinreb DB, Desman GT, Amolat-Apiado MJ, et al. Polyoma virus infection is a prominent risk factor for bladder carcinoma in immunocompetent individuals. Diagn Cytopathol 2006; 34:201.
  23. Chen Y, Trofe J, Gordon J, et al. BKV and JCV large T antigen-specific CD8+ T cell response in HLA A*0201+ kidney transplant recipients with polyomavirus nephropathy and patients with progressive multifocal leukoencephalopathy. J Clin Virol 2008; 42:198.
  24. Binggeli S, Egli A, Schaub S, et al. Polyomavirus BK-specific cellular immune response to VP1 and large T-antigen in kidney transplant recipients. Am J Transplant 2007; 7:1131.
  25. Luo C, Bueno M, Kant J, et al. Genotyping schemes for polyomavirus BK, using gene-specific phylogenetic trees and single nucleotide polymorphism analysis. J Virol 2009; 83:2285.
  26. Luo C, Bueno M, Kant J, Randhawa P. Biologic diversity of polyomavirus BK genomic sequences: Implications for molecular diagnostic laboratories. J Med Virol 2008; 80:1850.
  27. Purighalla R, Shapiro R, McCauley J, Randhawa P. BK virus infection in a kidney allograft diagnosed by needle biopsy. Am J Kidney Dis 1995; 26:671.
  28. Bodaghi S, Comoli P, Bösch R, et al. Antibody responses to recombinant polyomavirus BK large T and VP1 proteins in young kidney transplant patients. J Clin Microbiol 2009; 47:2577.
  29. Comoli P, Azzi A, Maccario R, et al. Polyomavirus BK-specific immunity after kidney transplantation. Transplantation 2004; 78:1229.
  30. Comoli P, Hirsch HH, Ginevri F. Cellular immune responses to BK virus. Curr Opin Organ Transplant 2008; 13:569.
  31. Dugan AS, Eash S, Atwood WJ. Update on BK virus entry and intracellular trafficking. Transpl Infect Dis 2006; 8:62.
  32. Elphick GF, Querbes W, Jordan JA, et al. The human polyomavirus, JCV, uses serotonin receptors to infect cells. Science 2004; 306:1380.
  33. Neu U, Maginnis MS, Palma AS, et al. Structure-function analysis of the human JC polyomavirus establishes the LSTc pentasaccharide as a functional receptor motif. Cell Host Microbe 2010; 8:309.
  34. Neu U, Stehle T, Atwood WJ. The Polyomaviridae: Contributions of virus structure to our understanding of virus receptors and infectious entry. Virology 2009; 384:389.
  35. Chesters PM, Heritage J, McCance DJ. Persistence of DNA sequences of BK virus and JC virus in normal human tissues and in diseased tissues. J Infect Dis 1983; 147:676.
  36. Egli A, Infanti L, Dumoulin A, et al. Prevalence of polyomavirus BK and JC infection and replication in 400 healthy blood donors. J Infect Dis 2009; 199:837.
  37. Polo C, Pérez JL, Mielnichuck A, et al. Prevalence and patterns of polyomavirus urinary excretion in immunocompetent adults and children. Clin Microbiol Infect 2004; 10:640.
  38. Drachenberg CB, Hirsch HH, Papadimitriou JC, et al. Polyomavirus BK versus JC replication and nephropathy in renal transplant recipients: a prospective evaluation. Transplantation 2007; 84:323.
  39. Hirsch HH, Knowles W, Dickenmann M, et al. Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients. N Engl J Med 2002; 347:488.
  40. Randhawa P, Uhrmacher J, Pasculle W, et al. A comparative study of BK and JC virus infections in organ transplant recipients. J Med Virol 2005; 77:238.
  41. Arthur RR, Shah KV, Charache P, Saral R. BK and JC virus infections in recipients of bone marrow transplants. J Infect Dis 1988; 158:563.
  42. Kitamura T, Sugimoto C, Kato A, et al. Persistent JC virus (JCV) infection is demonstrated by continuous shedding of the same JCV strains. J Clin Microbiol 1997; 35:1255.
  43. ASTROM KE, MANCALL EL, RICHARDSON EP Jr. Progressive multifocal leuko-encephalopathy; a hitherto unrecognized complication of chronic lymphatic leukaemia and Hodgkin's disease. Brain 1958; 81:93.
  44. ZURHEIN G, CHOU SM. PARTICLES RESEMBLING PAPOVA VIRUSES IN HUMAN CEREBRAL DEMYELINATING DISEASE. Science 1965; 148:1477.
  45. Lautenschlager I, Jahnukainen T, Kardas P, et al. A case of primary JC polyomavirus infection-associated nephropathy. Am J Transplant 2014; 14:2887.
  46. Kean JM, Rao S, Wang M, Garcea RL. Seroepidemiology of human polyomaviruses. PLoS Pathog 2009; 5:e1000363.
  47. Knowles WA. Discovery and epidemiology of the human polyomaviruses BK virus (BKV) and JC virus (JCV). Adv Exp Med Biol 2006; 577:19.
  48. Pastrana DV, Tolstov YL, Becker JC, et al. Quantitation of human seroresponsiveness to Merkel cell polyomavirus. PLoS Pathog 2009; 5:e1000578.
  49. Nicol JT, Robinot R, Carpentier A, et al. Age-specific seroprevalences of merkel cell polyomavirus, human polyomaviruses 6, 7, and 9, and trichodysplasia spinulosa-associated polyomavirus. Clin Vaccine Immunol 2013; 20:363.
  50. Nicol JT, Leblond V, Arnold F, et al. Seroprevalence of human Malawi polyomavirus. J Clin Microbiol 2014; 52:321.
  51. Zhong S, Randhawa PS, Ikegaya H, et al. Distribution patterns of BK polyomavirus (BKV) subtypes and subgroups in American, European and Asian populations suggest co-migration of BKV and the human race. J Gen Virol 2009; 90:144.
  52. Yogo Y, Sugimoto C, Zhong S, Homma Y. Evolution of the BK polyomavirus: epidemiological, anthropological and clinical implications. Rev Med Virol 2009; 19:185.
  53. Randhawa PS, Khaleel-Ur-Rehman K, Swalsky PA, et al. DNA sequencing of viral capsid protein VP-1 region in patients with BK virus interstitial nephritis. Transplantation 2002; 73:1090.
  54. Randhawa P, Viscidi R, Carter JJ, et al. Identification of species-specific and cross-reactive epitopes in human polyomavirus capsids using monoclonal antibodies. J Gen Virol 2009; 90:634.
  55. Cinque P, Dumoulin A, Hirsch HH. Diagnosis of Polyomavirus Infection, Replication and Disease. In: Jerome K, Laboratory Diagnosis of Viral Infections (Ed), Informa Healthcare USA, New York 2009. p.401.
  56. Sugimoto C, Hasegawa M, Kato A, et al. Evolution of human Polyomavirus JC: implications for the population history of humans. J Mol Evol 2002; 54:285.
  57. Cubitt CL. Molecular genetics of the BK virus. Adv Exp Med Biol 2006; 577:85.
  58. Schmidt T, Adam C, Hirsch HH, et al. BK polyomavirus-specific cellular immune responses are age-dependent and strongly correlate with phases of virus replication. Am J Transplant 2014; 14:1334.
  59. Knowles WA, Pipkin P, Andrews N, et al. Population-based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40. J Med Virol 2003; 71:115.
  60. Shah KV, Daniel RW, Warszawski RM. High prevalence of antibodies to BK virus, an SV40-related papovavirus, in residents of Maryland. J Infect Dis 1973; 128:784.
  61. Carter JJ, Paulson KG, Wipf GC, et al. Association of Merkel cell polyomavirus-specific antibodies with Merkel cell carcinoma. J Natl Cancer Inst 2009; 101:1510.
  62. Hirsch HH, Kardas P, Kranz D, Leboeuf C. The human JC polyomavirus (JCPyV): virological background and clinical implications. APMIS 2013; 121:685.
  63. Chen T, Hedman L, Mattila PS, et al. Serological evidence of Merkel cell polyomavirus primary infections in childhood. J Clin Virol 2011; 50:125.
  64. Tolstov YL, Pastrana DV, Feng H, et al. Human Merkel cell polyomavirus infection II. MCV is a common human infection that can be detected by conformational capsid epitope immunoassays. Int J Cancer 2009; 125:1250.
  65. Neske F, Prifert C, Scheiner B, et al. High prevalence of antibodies against polyomavirus WU, polyomavirus KI, and human bocavirus in German blood donors. BMC Infect Dis 2010; 10:215.
  66. Nguyen NL, Le BM, Wang D. Serologic evidence of frequent human infection with WU and KI polyomaviruses. Emerg Infect Dis 2009; 15:1199.
  67. Wieland U, Mauch C, Kreuter A, et al. Merkel cell polyomavirus DNA in persons without merkel cell carcinoma. Emerg Infect Dis 2009; 15:1496.
  68. Vanchiere JA, Abudayyeh S, Copeland CM, et al. Polyomavirus shedding in the stool of healthy adults. J Clin Microbiol 2009; 47:2388.
  69. Babakir-Mina M, Ciccozzi M, Alteri C, et al. Excretion of the novel polyomaviruses KI and WU in the stool of patients with hematological disorders. J Med Virol 2009; 81:1668.
  70. Vanchiere JA, Nicome RK, Greer JM, et al. Frequent detection of polyomaviruses in stool samples from hospitalized children. J Infect Dis 2005; 192:658.
  71. Wong AS, Cheng VC, Yuen KY, et al. High frequency of polyoma BK virus shedding in the gastrointestinal tract after hematopoietic stem cell transplantation: a prospective and quantitative analysis. Bone Marrow Transplant 2009; 43:43.
  72. Bofill-Mas S, Pina S, Girones R. Documenting the epidemiologic patterns of polyomaviruses in human populations by studying their presence in urban sewage. Appl Environ Microbiol 2000; 66:238.
  73. Bofill-Mas S, Formiga-Cruz M, Clemente-Casares P, et al. Potential transmission of human polyomaviruses through the gastrointestinal tract after exposure to virions or viral DNA. J Virol 2001; 75:10290.
  74. Goudsmit J, Wertheim-van Dillen P, van Strien A, van der Noordaa J. The role of BK virus in acute respiratory tract disease and the presence of BKV DNA in tonsils. J Med Virol 1982; 10:91.
  75. Babakir-Mina M, Ciccozzi M, Bonifacio D, et al. Identification of the novel KI and WU polyomaviruses in human tonsils. J Clin Virol 2009; 46:75.
  76. Kantola K, Sadeghi M, Lahtinen A, et al. Merkel cell polyomavirus DNA in tumor-free tonsillar tissues and upper respiratory tract samples: implications for respiratory transmission and latency. J Clin Virol 2009; 45:292.
  77. Monaco MC, Jensen PN, Hou J, et al. Detection of JC virus DNA in human tonsil tissue: evidence for site of initial viral infection. J Virol 1998; 72:9918.
  78. Kitamura T, Kunitake T, Guo J, et al. Transmission of the human polyomavirus JC virus occurs both within the family and outside the family. J Clin Microbiol 1994; 32:2359.
  79. Kunitake T, Kitamura T, Guo J, et al. Parent-to-child transmission is relatively common in the spread of the human polyomavirus JC virus. J Clin Microbiol 1995; 33:1448.
  80. Gibson PE, Field AM, Gardner SD, Coleman DV. Occurrence of IgM antibodies against BK and JC polyomaviruses during pregnancy. J Clin Pathol 1981; 34:674.
  81. Boldorini R, Allegrini S, Miglio U, et al. BK virus sequences in specimens from aborted fetuses. J Med Virol 2010; 82:2127.
  82. Low J, Humes HD, Szczypka M, Imperiale M. BKV and SV40 infection of human kidney tubular epithelial cells in vitro. Virology 2004; 323:182.
  83. Bernhoff E, Gutteberg TJ, Sandvik K, et al. Cidofovir inhibits polyomavirus BK replication in human renal tubular cells downstream of viral early gene expression. Am J Transplant 2008; 8:1413.
  84. Seemayer CA, Seemayer NH, Dürmüller U, et al. BK virus large T and VP-1 expression in infected human renal allografts. Nephrol Dial Transplant 2008; 23:3752.
  85. Ferenczy MW, Marshall LJ, Nelson CD, et al. Molecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain. Clin Microbiol Rev 2012; 25:471.
  86. Markowitz RB, Thompson HC, Mueller JF, et al. Incidence of BK virus and JC virus viruria in human immunodeficiency virus-infected and -uninfected subjects. J Infect Dis 1993; 167:13.
  87. Markowitz RB, Eaton BA, Kubik MF, et al. BK virus and JC virus shed during pregnancy have predominantly archetypal regulatory regions. J Virol 1991; 65:4515.
  88. Chapagain ML, Nerurkar VR. Human polyomavirus JC (JCV) infection of human B lymphocytes: a possible mechanism for JCV transmigration across the blood-brain barrier. J Infect Dis 2010; 202:184.
  89. Marshall LJ, Dunham L, Major EO. Transcription factor Spi-B binds unique sequences present in the tandem repeat promoter/enhancer of JC virus and supports viral activity. J Gen Virol 2010; 91:3042.
  90. Wüthrich C, Cheng YM, Joseph JT, et al. Frequent infection of cerebellar granule cell neurons by polyomavirus JC in progressive multifocal leukoencephalopathy. J Neuropathol Exp Neurol 2009; 68:15.
  91. Hirsch HH. Polyoma and Papilloma Virus Infections after Hematopoietic Stem Cell or Solid Organ Transplantation. In: Transplant Infections, Bowden P, Ljungman P, Snydman DR (Eds), Lippincott Williams & Wilkins, 2010. p.465.
  92. Hirsch HH. BK virus: opportunity makes a pathogen. Clin Infect Dis 2005; 41:354.
  93. Binet I, Nickeleit V, Hirsch HH. Polyomavirus infections in transplant recipients. Curr Opinion Organ Transplant 2000; 5:210.
  94. Hirsch HH, Kaufmann G, Sendi P, Battegay M. Immune reconstitution in HIV-infected patients. Clin Infect Dis 2004; 38:1159.
  95. Safdar A, Rubocki RJ, Horvath JA, et al. Fatal immune restoration disease in human immunodeficiency virus type 1-infected patients with progressive multifocal leukoencephalopathy: impact of antiretroviral therapy-associated immune reconstitution. Clin Infect Dis 2002; 35:1250.
  96. Kappos L, Bates D, Hartung HP, et al. Natalizumab treatment for multiple sclerosis: recommendations for patient selection and monitoring. Lancet Neurol 2007; 6:431.
  97. Geetha D, Tong BC, Racusen L, et al. Bladder carcinoma in a transplant recipient: evidence to implicate the BK human polyomavirus as a causal transforming agent. Transplantation 2002; 73:1933.
  98. Bredholt G, Olaussen E, Moens U, Rekvig OP. Linked production of antibodies to mammalian DNA and to human polyomavirus large T antigen: footprints of a common molecular and cellular process? Arthritis Rheum 1999; 42:2583.
  99. Fredriksen K, Osei A, Sundsfjord A, et al. On the biological origin of anti-double-stranded (ds) DNA antibodies: systemic lupus erythematosus-related anti-dsDNA antibodies are induced by polyomavirus BK in lupus-prone (NZBxNZW) F1 hybrids, but not in normal mice. Eur J Immunol 1994; 24:66.